Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 7Colorectal Neoplasms 5Rectal Neoplasms 4Colonic Neoplasms 3Neoplasm Metastasis 2Gastrointestinal Neoplasms 2Recurrence 1Rcctal Cancer 1Neoplasms 1Metastatic HER2 Positive Gastroesophageal Junction Cancer 1HER2-positive Locally Advanced Resectable Gastric Cancer 1Gastrointestinal Diseases 1Gastric Adenocarcinoma 1Digestive System Diseases 1Carcinoma 1Adenocarcinoma 1Adebrelimab (SHR-1316) 1

Interventions

XELOX 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Rcctal Cancer × XELOX × Clear all
NCT06808412 2025-02-05

To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer

Xijing Hospital of Digestive Diseases

Phase 2 Recruiting
118 enrolled

Rcctal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡